INIS
antibiotics
79%
barriers
28%
communities
45%
comparative evaluations
35%
control
56%
coronaviruses
32%
covid-19
69%
data
24%
diseases
42%
escherichia coli
23%
europe
21%
evaluation
37%
guidelines
28%
levels
23%
men
31%
netherlands
59%
nose
46%
patients
73%
people
53%
pneumonia
35%
risks
65%
sex
23%
staphylococcus
45%
strains
36%
streptococcus
28%
symptoms
28%
testing
23%
urinary tract
32%
women
49%
workers
24%
Keyphrases
Antibiotics
27%
Antimicrobial Resistance
42%
Chlamydia Trachomatis
21%
Commensal
25%
COVID-19
52%
COVID-19 Pandemic
36%
Dutch
100%
Escherichia Coli
20%
Europe
22%
European Countries
42%
General Practice
43%
General Practitioners
23%
Healthcare Workers
24%
Impact Evaluation
21%
Infection Control
50%
Infection Prevention
53%
Long-term Care Facilities
21%
Netherlands
60%
People with Developmental Disabilities
35%
People with Intellectual Disabilities
35%
Post-COVID-19
28%
Post-COVID-19 Condition
21%
Prevalence Risk
21%
Primary Care
34%
Residential Care Facilities
28%
Risk Factor Assessment
21%
Risk Impact
21%
Staphylococcus Aureus
48%
Streptococcus Pneumoniae
31%
Urinary Tract Infection
25%